Loading
Latest filing published 05 Jan 2022 for Strongbridge Biopharma plc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 5 January 2022, CDK Associates, L.L.C. disclosed a transaction in Strongbridge Biopharma plc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration